These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 21921261

  • 21. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G, Runkel S, Zdunek D, Hitzler WE.
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [Abstract] [Full Text] [Related]

  • 22. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA.
    JAMA; 2007 Jan 10; 297(2):169-76. PubMed ID: 17213400
    [Abstract] [Full Text] [Related]

  • 23. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
    Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S, AtheroGene Investigators.
    Eur Heart J; 2005 Feb 10; 26(3):241-9. PubMed ID: 15618051
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.
    Atherosclerosis; 2013 Jun 10; 228(2):478-84. PubMed ID: 23582589
    [Abstract] [Full Text] [Related]

  • 25. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Jun 10; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 26. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 10; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 27. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS.
    Int J Cardiol; 2008 Jun 06; 126(3):322-32. PubMed ID: 17544525
    [Abstract] [Full Text] [Related]

  • 28. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
    Hajsadeghi S, Kashani Amin L, Bakhshandeh H, Rohani M, Azizian AR, Jafarian Kerman SR.
    J Stroke Cerebrovasc Dis; 2013 May 06; 22(4):554-60. PubMed ID: 23422348
    [Abstract] [Full Text] [Related]

  • 29. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA.
    Kidney Blood Press Res; 2009 May 06; 32(5):373-9. PubMed ID: 19887825
    [Abstract] [Full Text] [Related]

  • 30. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, PEACE Investigators.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):205-14. PubMed ID: 17631211
    [Abstract] [Full Text] [Related]

  • 32. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q, Bárány P, Qureshi AR, Snaedal S, Heimburger O, Stenvinkel P, Lindholm B, Axelsson J.
    Am J Nephrol; 2009 Jul 17; 29(6):516-23. PubMed ID: 19077418
    [Abstract] [Full Text] [Related]

  • 33. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K, Yavavli A, Apak I, Ariturk Z, Toprak N.
    Am Heart J; 2006 May 17; 151(5):1115-22. PubMed ID: 16644347
    [Abstract] [Full Text] [Related]

  • 34. Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians.
    Vaes B, de Ruijter W, Degryse J, Westendorp RG, Gussekloo J.
    J Am Geriatr Soc; 2009 May 17; 57(5):823-9. PubMed ID: 19470010
    [Abstract] [Full Text] [Related]

  • 35. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
    Januzzi JL, Sakhuja R, O'donoghue M, Baggish AL, Anwaruddin S, Chae CU, Cameron R, Krauser DG, Tung R, Camargo CA, Lloyd-Jones DM.
    Arch Intern Med; 2006 Feb 13; 166(3):315-20. PubMed ID: 16476871
    [Abstract] [Full Text] [Related]

  • 36. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men.
    Laukkanen JA, Kurl S, Ala-Kopsala M, Vuolteenaho O, Ruskoaho H, Nyyssönen K, Salonen JT.
    Eur Heart J; 2006 May 13; 27(10):1230-7. PubMed ID: 16621869
    [Abstract] [Full Text] [Related]

  • 37. The value of NT-proBNP in early risk stratification of acute coronary syndromes.
    Almeida R, Mariano L, Gavina C, Pinho T, Vasconcelos M, Ferreira A, Maciel MJ, Gonçalves FR.
    Rev Port Cardiol; 2006 Jan 13; 25(1):71-5. PubMed ID: 16623357
    [Abstract] [Full Text] [Related]

  • 38. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657
    [Abstract] [Full Text] [Related]

  • 39. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.
    Wolber T, Maeder M, Rickli H, Riesen W, Binggeli C, Duru F, Ammann P.
    Eur J Clin Invest; 2007 Jan 25; 37(1):18-25. PubMed ID: 17181563
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?
    Finckh A, Courvoisier DS, Pagano S, Bas S, Chevallier-Ruggeri P, Hochstrasser D, Roux-Lombard P, Gabay C, Vuilleumier N.
    Arthritis Care Res (Hoboken); 2012 Jun 25; 64(6):817-25. PubMed ID: 22302385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.